Notify me when Mark E. Bunnage files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Scientific Officer | $3,542,573 | -$2,984,770 | -46% | 24 Feb 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|